New markers of fibrosis in hepatitis C: A step towards the Holy Grail?

In the present issue of the , Ferrassi examine the problem of liver fibrosis staging in chronic hepatitis C. They identify novel biomarkers in an effort to predict accurate fibrosis staging with the aid of the metabolome of Hepatitis C patients. Overall I think Ferrassi took a different approach in identifying fibrosis biomarkers, by looking at the patients' metabolome.